Omniscan (Gadodiamide)

Omniscan is a gadolinium‑based contrast agent used in magnetic resonance imaging to improve visualization of anatomical structures and pathological conditions.

• Central nervous system imaging: enhances detection of lesions, tumors, and vascular abnormalities.
• Cardiovascular imaging: improves delineation of cardiac chambers, vessels, and myocardial perfusion.
• Whole‑body and oncologic imaging: aids in identifying metastatic disease and evaluating treatment response.

• Gadodiamide is a gadolinium‑based chelate that shortens the T1 relaxation time of nearby water protons during MRI. By altering local magnetic properties, it increases signal intensity on T1‑weighted images, providing clearer contrast between normal and abnormal tissues without interacting with specific cellular receptors.

Adverse reactions to gadodiamide‑based contrast agents are generally infrequent but can vary in severity.

Common Side Effects

• Nausea: mild and transient.
• Headache: occasional during or after injection.
• Injection site discomfort: mild pain or warmth at the site.
• Warm sensation: brief feeling of heat throughout the body.
• Metallic taste: transient metallic sensation in the mouth.
• Dizziness: mild, short‑lived episodes.

Serious or Rare Side Effects

• Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment.
• Anaphylactoid reactions: hives, bronchospasm, or hypotension.
• Severe hypersensitivity: angio‑edema or respiratory distress.
• Cardiac arrest: rare but life‑threatening event.
• Renal toxicity: acute kidney injury in susceptible individuals.
• Death: extremely rare, reported in severe anaphylactic cases.

When administering Omniscan, clinicians should assess patient risk factors and follow recommended safety protocols.

• Renal function assessment: evaluate glomerular filtration rate before use.
• History of allergic reactions: review prior contrast media reactions.
• Pregnancy considerations: use only if essential, after risk‑benefit analysis.
• Pediatric use: adjust dosing based on weight and clinical need.
• Concomitant nephrotoxic drugs: avoid or monitor closely.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Gadodiamide may interact with other agents that affect renal function or hypersensitivity risk.

Major Interactions (Avoid)

• Nephrotoxic antibiotics (e.g., aminoglycosides): increase risk of renal injury.
• High‑dose intravenous iron: may alter gadolinium clearance.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may affect fluid balance and renal excretion.
• ACE inhibitors/ARBs: monitor kidney function when combined.
• Metformin: assess renal function to avoid lactic acidosis risk.
• NSAIDs: increased potential for renal impairment.
• Calcium channel blockers: observe for any unexpected reactions.